Kevin Dolgin has worked as a senior international consultant in marketing and strategy for the pharmaceutical industry for over 20 years. He is also an Associate Professor in management at Université de Paris I. Before Observia, he created the Areks, now part of IMS Health. He has an undergraduate degree from Fordham University, an MBA from INSEAD and a Master of Research from the Sorbonne. Observia is one of Europe’s foremost companies in the domain of adherence, focusing on digital health programs to improve patient outcomes. Observia’s mission is to help chronic patients adhere to the treatment given by their healthcare professional.